More and more companies are leveraging NeuroFlow’s robust platform to deliver the next generation of integrated care. Building on the evidence-based and clinically validated psychiatric collaborative care model, NeuroFlow’s ‘CoCM 2.0’ solution expands a tech-enabled approach beyond the model’s foundational registry requirements to help providers support more patients, facilitate faster recovery, and support patient health long-term. The result is increased efficiency and higher ROI of clients’ programs and services.

While the model’s positive outcomes have been heavily researched, CoCM adoption has remained low because it can be challenging to ramp up these programs quickly, affordably, and at scale. Despite the boom in technology in the past 30 years – high-speed internet, the rise of smartphones, and the emergence of artificial intelligence – many health systems still attempt integrated care models utilizing the same spreadsheet-based registries developed decades ago.

NeuroFlow is changing this narrative by establishing a technology infrastructure that supports population-level scale and improves program efficiency, offering a better experience for both providers and their patients.

NeuroFlow enables a population-wide approach to behavioral health management that identifies and supports patient BH at scale, extends care into the patient’s home, and monitors their progress longitudinally. The results are powerful; NeuroFlow customers typically see a 17-23% increase in early identification of BH in their patients, and efficient clinical workflows increase caseload capacity by nearly 36-40% annually. All of this is done while achieving a 90% satisfaction rate among care teams, supporting reduction in clinical burnout.